MARKET

HOLX

HOLX

Hologic
NASDAQ

Real-time Quotes | Nasdaq Last Sale

64.93
+0.46
+0.71%
Opening 10:17 06/24 EDT
OPEN
64.96
PREV CLOSE
64.47
HIGH
65.10
LOW
64.79
VOLUME
282.10K
TURNOVER
--
52 WEEK HIGH
85.00
52 WEEK LOW
53.02
MARKET CAP
16.64B
P/E (TTM)
8.91
1D
5D
1M
3M
1Y
5Y
Hologic (HOLX) Gets European Nod for Aptima CMV Quant Assay
Zacks.com · 3h ago
Hologic's Aptima CMV Quant assay secures European CE mark
Hologic (HOLX) has received CE mark for its new Aptima CMV Quant assay in Europe.This assay, which quantifies the viral load of human cytomegalovirus ((CMV)), is intended for use to
Seekingalpha · 1d ago
BRIEF-Hologic Receives European CE Mark For Molecular Assay To Quantify Human Cytomegalovirus
reuters.com · 1d ago
Hologic Receives European CE Mark for Molecular Assay to Quantify Human Cytomegalovirus
Hologic, Inc. (Nasdaq: HOLX) has received CE mark for its new Aptima(R) CMV Quant assay in Europe, the Company announced today. This assay, which quantifies the viral load of human cytomegalovirus (CMV), is intended for use to aid in the diagnosis and mana...
Business Wire · 1d ago
Hologic Receives CE Mark for Human Cytomegalovirus Quant Assay
MT Newswires · 1d ago
Hologic Inc. stock rises Tuesday, outperforms market
marketwatch.com · 1d ago
Microbiology Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth To 2030
Reportlinker.com announces the release of the report "Microbiology Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth To 2030" - https://www.reportlinker.com/p06097016/?utm_source=GNW
GlobeNewswire · 2d ago
Hologic Inc. stock rises Monday, still underperforms market
marketwatch.com · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of HOLX. Analyze the recent business situations of Hologic through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average HOLX stock price target is 82.92 with a high estimate of 95.00 and a low estimate of 73.00.
EPS
Institutional Holdings
Institutions: 843
Institutional Holdings: 255.03M
% Owned: 99.53%
Shares Outstanding: 256.23M
TypeInstitutionsShares
Increased
260
14.91M
New
77
712.62K
Decreased
195
12.57M
Sold Out
67
3.27M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.35%
Healthcare Equipment & Supplies
+0.59%
Key Executives
Chairman/President/Chief Executive Officer/Director
Stephen MacMillan
Chairman/President/Chief Executive Officer/Director
Stephen Macmillan
Chief Financial Officer
Karleen Oberton
Corporate Executive
Sanjay Prabhakaran
Corporate Executive
Kevin Thornal
Senior Vice President/Director of Human Resources
Allison Bebo
General Counsel
John Griffin
Corporate Executive
Jan Verstreken
Lead Director/Independent Director
Sally Crawford
Chief Accounting Officer
Benjamin Cohn
Independent Director
Charles Dockendorff
Vice President/IR Contact Officer
Michael Watts
Independent Director
Scott Garrett
Independent Director
Ludwig Hantson
Independent Director
Namal Nawana
Independent Director
Christiana Stamoulis
Independent Director
Amy Wendell
No Data
  • All
  • Financials
  • Insiders
More
About HOLX
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Webull offers kinds of Hologic, Inc. stock information, including NASDAQ:HOLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HOLX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HOLX stock methods without spending real money on the virtual paper trading platform.